Robin Dosan is a bioinformatician focused on genomics, immunology, and clinical data interoperability.
- 01
YOLO Document Segmentation for OCR
Training and evaluation pipeline for a YOLO model on photographed health documents.
- Computer vision
- YOLO
- OCR
- Document AI
- 02
SARS-CoV-2 Genomic Analysis to FHIR
Pipeline for SARS-CoV-2 variant, lineage, and clade analysis with FHIR Genomics clinical reporting.
- Nextflow
- SARS-CoV-2
- FHIR
- Pathogen genomics
- 03
COVID-19 scRNA-seq: Immune Severity and Clonal Hematopoiesis
Replication of Choi et al. 2022: single-cell transcriptome analysis of COVID-19 PBMC immune landscape.
- Seurat
- scRNA-seq
- Immunology
- COVID-19
- 04
PhIP-Seq Analysis Pipeline for ONT
Pipeline for Phage Immunoprecipitation Sequencing (PhIP-Seq) analysis using Oxford Nanopore (ONT).
- Nextflow
- Immunology
- High-throughput
- 05
Bifidobacterium breve PS1 WGS analysis
Whole-genome reconstruction of Bifidobacterium breve PS1 highlighting substrate predictions and probiotic potential.
- Whole genome sequencing
- Microbiome genomics
- Probiotics
- 06
Dengue Genomic Analysis to FHIR
Pipeline for pan-serotype Dengue virus genomic analysis (Illumina and Nanopore) with FHIR Genomics clinical reporting.
- Nextflow
- Dengue virus
- Viral genomics
- FHIR
- Pathogen genomics
- 07
Deeplex Myc-TB to FHIR
Pipeline for analyzing Deeplex Myc-TB targeted sequencing (tNGS) outputs into FHIR Genomics clinical reporting.
- Nextflow
- Mycobacterium tuberculosis
- Drug resistance
- FHIR
- Pathogen genomics
- 08
KP Genomic Analysis to FHIR
Pipeline for Klebsiella pneumoniae genomic analysis (Illumina, Nanopore) with FHIR Genomics clinical reporting.
- Nextflow
- Klebsiella pneumoniae
- Drug resistance
- FHIR
- Pathogen genomics
- 09
TB Genomic Analysis to FHIR
Pipeline for TB resistance and lineage analysis (Illumina, Nanopore, and VCF) with FHIR Genomics clinical reporting.
- Nextflow
- Mycobacterium tuberculosis
- Drug resistance
- FHIR
- Pathogen genomics
